LCMS Bioanalysis
Method development driven by diagnostic probes and a 3-tier study design to improve data quality and speed simultaneously.
Drug Discovery is Complex.
You Need a Personalized Approach.
Meadowhawk offers quantitative bioanalysis based on LCMS and ligand binding technology platforms; in conjunction with AAALAC accredited rodent vivarium facilities on both coasts, we are primed to deliver the highest quality data in the shortest time possible.
While each client’s path at Meadowhawk is tailored to their unique needs, every program draws upon our deep and specialized in-vivo and bioanalytical experiences supporting discovery research.
Rodent In Vivo
Benchmark Pharmacokinetic (PK) and complex PK/PD studies to support both quick and complex needs.
Immunoanalytical
Ligand binding assays to analyze samples for PK, ADA and biomarkers; flow cytometry to analyze cell based biomarkers.
Meeting Your CRO Needs
With processes and infrastructure built around a discovery stage focus, our broad experience and expertise with different drug modality types ensures you get the data you need to advance your study. Supported by a seasoned team with decades of experience, all studies receive a senior scientist as the single point of contact to support the shortest possible turnaround times and most timely and transparent communication.
...all studies receive a senior scientist as the single point of contact to support the shortest possible turnaround times.
Finding Your Path to Success
We know there’s a lot at stake. Learn more about how we help clients advance their drug discovery and development work in order to bring therapeutics to market – on time and on budget.
View Our Case Studies